Viravaxx presents poster at AASLD
Vienna, Nov 15, 2021. Petra Steindl-Munda and Peter Ferenci, scientific advisors for Viravaxx, will present interim-data of Viravaxx’ ongoing VVX001 clinical study in poster sessions entitled: “Vaccination with the preS-based grass pollen allergy vaccine VVX001 enhances HBV virus-specific immunity in vivo”. The posters will be presented at AASLD (American Association for the Study of Liver | read more ยป
Vienna, Nov 15, 2021. Petra Steindl-Munda and Peter Ferenci, scientific advisors for Viravaxx, will present interim-data of Viravaxx’ ongoing VVX001 clinical study in poster sessions entitled: “Vaccination with the preS-based grass pollen allergy vaccine VVX001 enhances HBV virus-specific immunity in vivo”. The posters will be presented at AASLD (American Association for the Study of Liver Diseases) in Nov 2021, and at HepDART in Dec 2021.